NEW YORK, Oct. 30 - The Michigan Proteome Consortium has received an $11.9-million, five-year grant from the NIH's National Center for Research Resources to further develop its proteomics technologies, according to an Oct. 28. press statement from the NCCR.
Â
The consortium, which is led by Philip Andrews, a professor of biological chemistry at the University of Michigan Medical School, has to date received $28 million in funding from the NIH, the University, and other sources. The Michigan Life Sciences Corridor, a non-profit organization to promote life sciences in the state, provided the consortium with a $13.7 million start-up grant in 2001.
Â
"This additional funding from the National Center for Research Resources will make it possible for the Consortium to expand its R&D program in emerging proteomics technologies," Andrews said in a statement. "For proteomics to reach its full potential, we need to develop more sensitive techniques for use with smaller tissue specimens, new mapping technologies, and improved software and computational tools."
Â